Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07413432 · ClinicalTrials.gov registry record · NA
A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT07413432: Completed NA study, sponsored by Yale University.
NCT07413432 is a NA study that has completed, run by Yale University. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07413432, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The goal of this study is to develop and test an adapted version of our virtual reality videogame intervention prototype, Invite Only VR, developed for middle school students, which focuses on e-cigarette and marijuana vaping prevention. The game also includes a focus on emotion regulation and healthy coping skills. To determine the preliminary impact of the intervention, investigators will collect acceptability and feasibility data from 6th-8th grade students across three Connecticut middle schools. Investigators will also collect data on participants' knowledge, harm perceptions, and intentions to vape before and after they have played the videogame intervention.
Primary Outcome
Feasibility will be measured the number of participants that completed the assigned intervention.
Interventions
- BEHAVIORAL Virtual reality videogame intervention for vaping prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2025-09-26 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What the finished NCT07413432 record still lists
NCT07413432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtual reality videogame intervention for vaping prevention is the first listed.
NCT07413432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07413432 about?
NCT07413432 is a clinical study titled "A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping". The goal of this study is to develop and test an adapted version of our virtual reality videogame intervention prototype, Invite Only VR, developed for middle school students, which focuses on e-cigarette and marijuana vaping prevention. The game also includes a focus on emotion regulation and healt...
What is the current status of trial NCT07413432?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2025-09-26. Estimated completion is 2025-12-30.
What interventions are being tested in trial NCT07413432?
The interventions under investigation include: Virtual reality videogame intervention for vaping prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07413432?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07413432's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI